Efficiency of Antiviral Therapy for Recurrence of Chronic Hepatitis C in Patients Undergoing Liver Transplantation

QR Code

Efficiency of Antiviral Therapy for Recurrence of Chronic Hepatitis C in Patients Undergoing Liver Transplantation

In the article the analysis data of observation and treatment recurrence hepatits C after liver transplantation. When performing operations on the background of the current active infection relapse is inevitable, and progression is fast. The effectiveness of antiviral therapy for immunosuppression i...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. A. Sukhoruk, E. V. Esaulenko, A. A. Yakovlev, I. V. Khomchenko
Format:	Article
Language:	Russian
Published:	Journal Infectology 2014-09-01
Series:	Журнал инфектологии
Subjects:	hepatitis c liver transplantation recurrence antiviral therapy
Online Access:	https://journal.niidi.ru/jofin/article/view/184
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TREATMENT OF HEPATITIS C WITHOUT INTERFERON IN PATIENTS UNDERGOING LIVER TRANSPLANTATION
by: M. Sh. Khubutia, et al.
Published: (2015-10-01)

POSSIBILITIES OF HEPATITIS C ANTIVIRAL TREATMENT IN LIVER TRANSPLANT RECIPIENTS
by: V. E. Syutkin, et al.
Published: (2011-06-01)

Changes in graft density after effective treatment of recurrent hepatitis C in liver transplant recipients during long-term follow-up
by: V. E. Syutkin, et al.
Published: (2024-12-01)

The use of telaprevir for the treatment of hepatitis C in patients undergoing liver transplantation (Literature review and clinical experience)
by: M. Sh. Khubutiya, et al.
Published: (2016-02-01)

Antiviral therapy of hepatitis C with 1 genotype after liver transplantation
by: O. M. Tsiroulnikova, et al.
Published: (2018-09-01)

Treatment of hepatitis C in liver transplant recipients in the Moscow Center for Liver Transplantation within 10 years
by: M. Sh. Khubutia, et al.
Published: (2016-01-01)

PHARMACOECONOMIC ASSESSMENT OF USING INTERFERON-FREE REGIMENS FOR CHRONIC HEPATITIS C AFTER LIVER TRANSPLANTATION
by: A. A. Sukhoruk, et al.
Published: (2016-06-01)

The use of sofosbuvir for the treatment of recurrent hepatitis C after liver transplantation
by: M. Sh. Khubutiya, et al.
Published: (2017-03-01)

The efficacy and safety of antiviral drugs of direct action in liver recipients with recurrence of chronic hepatitis C genotype 1 after transplantation
by: О. M. Tsiroulnikova, et al.
Published: (2019-01-01)

Outcomes of liver transplantation in the era of modern antiviral therapy for hepatitis C
by: K. Yu. Kokina, et al.
Published: (2021-04-01)

Liver cirrhosis as a result of chronic hepatitis C
by: A. A. Sukhoruk, et al.
Published: (2014-09-01)

Liver graft dysfunction due to hepatitis C infection
by: V. E. Syutkin, et al.
Published: (2018-08-01)

Experience of effective antiviral therapy in a liver recipient with recurrent HCV infection genotype 1
by: D. V. Umrik, et al.
Published: (2019-01-01)

Efficacy of antiviral therapy in the treatment of severe forms of acute hepatitis B
by: E. V. Esaulenko, et al.
Published: (2016-02-01)

Treatment for recurrent HCV infection after liver transplantation for final stages of chronic hepatitis С
by: V. E. Syutkin, et al.
Published: (2018-08-01)

Liver CT Perfusion Imaging as a Non-Invasive Method for Assessing Hemodynamics of the Hepatic Parenchyma in Patients with Fibrosis and Cirrhosis as a Result of Chronic Viral Hepatitis C
by: G. A. Stashuk, et al.
Published: (2022-02-01)

EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2017-01-01)

Clinico-laboratory and immunological characteristics of patients with compensated cirrhosis of the liver in the outcome of chronic hepatitis C on the background of treatment with a direct antiviral drug paritrapeprir/ritonavir/ombitasvir/ dasabuvir
by: L. L. Popova, et al.
Published: (2018-12-01)

Seronegative fibrosing cholestatic hepatitis С after liver retransplantation for unresectable neuroendocrine tumor liver metastases
by: S. E. Voskanyan, et al.
Published: (2020-12-01)

Direct-acting antiviral therapy for patients with hepatitis C virus-related hepatocellular carcinoma: A nationwide cohort study
by: Shou-Wu Lee, et al.
Published: (2025-07-01)

Iron metabolism in chronic hepatitis C patients on antiviral treatment
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C
by: I. A. Narkevich, et al.
Published: (2024-02-01)

Planning a clinical trial programme for direct-acting antivirals for chronic viral hepatitis C
by: A. I. Gubenko, et al.
Published: (2023-12-01)

Adverse Effects of Combined Antiviral Therapy of Chronic Hepatitis C Virus and Methods for It’s Correction
by: Y. M. Ambalov, et al.
Published: (2011-09-01)

Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease Specialists for the Diagnosis and Treatment of Chronic Hepatitis C
by: V. T. Ivashkin, et al.
Published: (2023-06-01)

Antiviral therapy for chronic hepatitis C: is there a time to change existing standards?
by: D. T. Abdurakhmanov
Published: (2009-02-01)

Chronic hepatitis C course at elderly and therapeutic approach
by: M. V. Mayevskaya, et al.
Published: (2011-02-01)

Protein C in a patient with portal vein thrombosis in liver transplantation
by: S. V. Zhuravel, et al.
Published: (2021-06-01)

Successful antiviral therapy for chronic hepatitis C in a patient after surgery for hepatocellular carcinoma (a clinical observation)
by: I. G. Nikitin, et al.
Published: (2018-08-01)

Waiting list changes and follow-up of anti-HCV positive liver transplant recipients: an analysis of 400 cases out of 1000 transplantations
by: V. E. Syutkin, et al.
Published: (2023-12-01)

Efficacy of direct-acting antivirals in patients with hepatitis C virus-associated cryoglobulinemic vasculitis: Results of a long-term follow-up
by: S. V. Gavrisheva, et al.
Published: (2023-04-01)

The management of the hepatic artery thrombosis after liver transplantation
by: V. L. Korobka, et al.
Published: (2020-12-01)

Effects of antiviral therapy on reducing the risk of metabolic syndrome in patients with chronic hepatitis C
by: A. F. Novikova, et al.
Published: (2023-07-01)

Change of the indices of the cytokine status in patients with chronic combined hepatitis B+C in a process of antiviral therapy
by: O. L. Sobolevskaya
Published: (2014-09-01)

Success of early antiviral monotherapy with pegylated interferon α-2a for posttransplantation fibrosing cholestatic hepatitis C (a clinical case)
by: A. V. Chzhao, et al.
Published: (2018-08-01)

Evaluation of ten years of experience in managing patients with hepatic encephalopathy on the waiting list for liver transplantation in the Rostov region
by: E. S. Pak, et al.
Published: (2024-06-01)

Liver fibrosis assessment by transient elastography in patients with liver cirrhosis after hepatitis C virus eradication
by: E. A. Nabatchikova, et al.
Published: (2020-03-01)

RESULTS OF THE USE OF SOFOSBUVIR IN COMBINATION WITH LEDIPASVIR OR DACLATASVIR FOR CHRONIC HEPATITIS C TREATMENT IN THE REPUBLIC OF BELARUS
by: S. V. Zhavoronok, et al.
Published: (2018-10-01)

Treatment of the chronic hepatitis C complicated by mixed cryoglobulinemia with direct-acting antiviral agents
by: N. V. Dunaeva, et al.
Published: (2018-12-01)

Cirrhosis of the liver and hepatocellular carcinoma in the outcome of chronic hepatitis C: a case report
by: V. V. Makashova, et al.
Published: (2023-04-01)